Author

Olha Sviatenka

Browsing

On 3 May 2022, the parliament of Ukraine adopted in the first reading the draft law No. 7313 (“Draft Law”), aiming to prevent the turnover of pharmaceuticals manufactured in Russia or Belarus, or marketed by marketing authorization holders with ties to pharmaceutical manufacturing in these countries. The restrictions set forth in the Draft Law are discussed below. Cancellation or refusal in marketing authorization Based on the current wording of the Draft Law, the Ministry of…